
Kardigan develops personalized cardiovascular medicines intended to move patients beyond symptom management toward functional cures. The company uses a proprietary Cardiac Intelligence R&D platform…

Kardigan develops personalized cardiovascular medicines intended to move patients beyond symptom management toward functional cures. The company uses a proprietary Cardiac Intelligence R&D platform…
Your next opportunity is in here somewhere. Sign up to explore 52,000+ startups and their open roles. No spam. No gamification. Just jobs.
52,000+
Startups
65,000+
Open Roles
1,500+
New This Week
About Us Kardigan is a heart health company working to make cardiovascular disease preventable, curable and no longer the leading cause of death in the world.
It is Kardigan’s mission to develop multiple targeted treatments in parallel that bring people with cardiovascular diseases to the cures they deserve.
Led by Tassos Giannakakos, Jay Edelberg, M.D., Ph.D., and Bob McDowell, Ph.D., Kardigan’s co-founders have reunited after leading MyoKardia to discover and develop mavacamten, the first cardiac myosin inhibitor, resulting in an acquisition by Bristol Myers Squibb in 2020.
We have a cutting-edge discovery and translational research platform, a pipeline of late-stage candidates, and an industry-leading team that is driven to improve the lives of patients.
At Kardigan, we are motivated by our values which guide how we work, interact, and achieve our goals. Driven by patients and their families , we are deeply committed to improving the lives of patients and prioritizing their needs above all else. We believe in being authentic —leading with truth to bring out the best in others by creating an environment where every person knows they will be fully accepted. With an eagerness to learn , we encourage the highest levels of curiosity and are open to changing our minds. We are committed to winning as a team with urgency, excellence, and intention, and support each other no matter what role we play or where we sit. Lastly, we strive to enable the impossible because patients are counting on us. We are not afraid to take risks to unlock innovation and advance scientific discoveries.
These values are the foundation of our work, empowering us to make a real difference, every day.
Position Title: Director, Medical Science Liaison / Regional Medical Lead – Cardiovascular
Department: Medical Affairs
Reports To: Head of Medical Affairs (ad interim – will report to National Director of Field Medical)
Location: Field-Based (Regional)
Job Overview The Director, Medical Science Liaison (MSL) / Regional Medical Lead (RML) serves as a field-based scientific leader responsible for advancing the medical strategy within a defined region. This role combines traditional MSL responsibilities with regional leadership oversight, strategic execution, and cross-functional collaboration to support cardiovascular assets across approved products and pipeline programs.
The individual acts as a scientific expert in cardiovascular disease (e.g., heart failure, cardiomyopathies, hypertension, cardiometabolic disease, etc.), builds trusted partnerships with key opinion leaders (KOLs), and drives regional medical excellence aligned with global and U.S. medical strategy.
Essential Duties And Responsibilities Scientific Engagement & KOL Development (MSL Function)
Regional Medical Leadership Responsibilities As a Regional Medical Lead, additional responsibilities include:
Clinical & Research Support
Compliance & Governance
Qualifications And Preferred Skills Education
Experience
Expertise Areas May Include
Exact Compensation may vary based on skills, experience and location.
Pay range
$257,000 - $335,000 USD